1. SongMJ, HwangS, WongWH, WuTT, LeeS, et al. (2005) Identification of viral genes essential for replication of murine gamma-herpesvirus 68 using signature-tagged mutagenesis. Proceedings of the National Academy of Sciences of the United States of America 102: 3805–3810.
2. ArumugaswamiV, WuTT, Martinez-GuzmanD, JiaQ, DengH, et al. (2006) ORF18 is a transfactor that is essential for late gene transcription of a gammaherpesvirus. J Virol 80: 9730–9740.
3. WongE, WuTT, ReyesN, DengH, SunR (2007) Murine gammaherpesvirus 68 open reading frame 24 is required for late gene expression after DNA replication. J Virol 81: 6761–6764.
4. WuTT, ParkT, KimH, TranT, TongL, et al. (2009) ORF30 and ORF34 are essential for expression of late genes in murine gammaherpesvirus 68. J Virol 83: 2265–2273.
5. PerngYC, QianZ, FehrAR, XuanB, YuD (2011) The human cytomegalovirus gene UL79 is required for the accumulation of late viral transcripts. Journal of virology 85: 4841–4852.
6. IsomuraH, StinskiMF, MurataT, YamashitaY, KandaT, et al. (2011) The human cytomegalovirus gene products essential for late viral gene expression assemble into prereplication complexes before viral DNA replication. Journal of virology 85: 6629–6644.
7. WyrwiczLS, RychlewskiL (2007) Identification of Herpes TATT-binding protein. Antiviral research 75: 167–172.
8. GruffatH, KadjoufF, MariameB, ManetE (2012) The Epstein-Barr virus BcRF1 gene product is a TBP-like protein with an essential role in late gene expression. Journal of virology 86: 6023–6032.
9. SerioTR, CahillN, ProutME, MillerG (1998) A functionally distinct TATA box required for late progression through the Epstein-Barr virus life cycle. Journal of Virology 72: 8338–8343.
10. IsomuraH, StinskiMF, KudohA, MurataT, NakayamaS, et al. (2008) Noncanonical TATA sequence in the UL44 late promoter of human cytomegalovirus is required for the accumulation of late viral transcripts. Journal of virology 82: 1638–1646.
11. TangS, YamanegiK, ZhengZM (2004) Requirement of a 12-base-pair TATT-containing sequence and viral lytic DNA replication in activation of the Kaposi's sarcoma-associated herpesvirus K8.1 late promoter. J Virol 78: 2609–2614.
12. HeilmannAM, CalderwoodMA, PortalD, LuY, JohannsenE (2012) Genome-wide analysis of epstein-barr virus rta DNA binding. Journal of virology 86: 5151–5164.
13. ChuaHH, LeeHH, ChangSS, LuCC, YehTH, et al. (2007) Role of the TSG101 gene in Epstein-Barr virus late gene transcription. J Virol 81: 2459–2471.
14. WingBA, JohnsonRA, HuangES (1998) Identification of positive and negative regulatory regions involved in regulating expression of the human cytomegalovirus UL94 late promoter: role of IE2-86 and cellular p53 in mediating negative regulatory function. J Virol 72: 1814–1825.
15. DeMerittIB, PodduturiJP, TilleyAM, NogalskiMT, YurochkoAD (2006) Prolonged activation of NF-kappaB by human cytomegalovirus promotes efficient viral replication and late gene expression. Virology 346: 15–31.
16. ChenMR, ChangSJ, HuangH, ChenJY (2000) A protein kinase activity associated with Epstein-Barr virus BGLF4 phosphorylates the viral early antigen EA-D in vitro. J Virol 74: 3093–3104.
17. GershburgE, PaganoJS (2008) Conserved herpesvirus protein kinases. Biochim Biophys Acta 1784: 203–212.
18. RomakerD, SchregelV, MaurerK, AuerochsS, MarziA, et al. (2006) Analysis of the structure-activity relationship of four herpesviral UL97 subfamily protein kinases reveals partial but not full functional conservation. J Med Chem 49: 7044–7053.
19. KunyCV, ChinchillaK, CulbertsonMR, KalejtaRF (2010) Cyclin-dependent kinase-like function is shared by the beta- and gamma- subset of the conserved herpesvirus protein kinases. PLoS pathogens 6: e1001092.
20. KawaguchiY, KatoK, TanakaM, KanamoriM, NishiyamaY, et al. (2003) Conserved protein kinases encoded by herpesviruses and cellular protein kinase cdc2 target the same phosphorylation site in eukaryotic elongation factor 1delta. J Virol 77: 2359–2368.
21. LeeCP, ChenJY, WangJT, KimuraK, TakemotoA, et al. (2007) Epstein-Barr virus BGLF4 kinase induces premature chromosome condensation through activation of condensin and topoisomerase II. J Virol 81: 5166–5180.
22. ChenPW, LinSJ, TsaiSC, LinJH, ChenMR, et al. (2010) Regulation of microtubule dynamics through phosphorylation on stathmin by Epstein-Barr virus kinase BGLF4. J Biol Chem 285: 10053–10063.
23. ZhuJ, LiaoG, ShanL, ZhangJ, ChenMR, et al. (2009) Protein array identification of substrates of the Epstein-Barr virus protein kinase BGLF4. J Virol 83: 5219–5231.
24. IwahoriS, MurataT, KudohA, SatoY, NakayamaS, et al. (2009) Phosphorylation of p27Kip1 by Epstein-Barr virus protein kinase induces its degradation through SCFSkp2 ubiquitin ligase actions during viral lytic replication. J Biol Chem 284: 18923–18931.
25. KudohA, DaikokuT, IshimiY, KawaguchiY, ShirataN, et al. (2006) Phosphorylation of MCM4 at sites inactivating DNA helicase activity of the MCM4-MCM6-MCM7 complex during Epstein-Barr virus productive replication. Journal of virology 80: 10064–10072.
26. KatoK, KawaguchiY, TanakaM, IgarashiM, YokoyamaA, et al. (2001) Epstein-Barr virus-encoded protein kinase BGLF4 mediates hyperphosphorylation of cellular elongation factor 1delta (EF-1delta): EF-1delta is universally modified by conserved protein kinases of herpesviruses in mammalian cells. J Gen Virol 82: 1457–1463.
27. LeeCP, HuangYH, LinSF, ChangY, ChangYH, et al. (2008) Epstein-Barr virus BGLF4 kinase induces disassembly of the nuclear lamina to facilitate virion production. J Virol 82: 11913–11926.
28. MengQ, HagemeierSR, KunyCV, KalejtaRF, KenneySC (2010) Simian virus 40 T/t antigens and lamin A/C small interfering RNA rescue the phenotype of an Epstein-Barr virus protein kinase (BGLF4) mutant. J Virol 84: 4524–4533.
29. SunX, BristolJA, IwahoriS, HagemeierSR, MengQ, et al. (2013) Hsp90 inhibitor 17-DMAG decreases expression of conserved herpesvirus protein kinases and reduces virus production in Epstein-Barr virus-infected cells. Journal of virology 87: 10126–10138.
30. KugaT, NozakiN, MatsushitaK, NomuraF, TomonagaT (2010) Phosphorylation statuses at different residues of lamin B2, B1, and A/C dynamically and independently change throughout the cell cycle. Experimental cell research 316: 2301–2312.
31. GershburgE, RaffaS, TorrisiMR, PaganoJS (2007) Epstein-Barr virus-encoded protein kinase (BGLF4) is involved in production of infectious virus. J Virol 81: 5407–5412.
32. MurataT, IsomuraH, YamashitaY, ToyamaS, SatoY, et al. (2009) Efficient production of infectious viruses requires enzymatic activity of Epstein-Barr virus protein kinase. Virology 389: 75–81.
33. WangJT, ChuangYC, ChenKL, LuCC, DoongSL, et al. (2010) Characterization of Epstein-Barr virus BGLF4 kinase expression control at the transcriptional and translational levels. J Gen Virol 91: 2186–2196.
34. WangJT, YangPW, LeeCP, HanCH, TsaiCH, et al. (2005) Detection of Epstein-Barr virus BGLF4 protein kinase in virus replication compartments and virus particles. J Gen Virol 86: 3215–3225.
35. SugimotoA, SatoY, KandaT, MurataT, NaritaY, et al. (2013) Different distributions of Epstein-Barr virus early and late gene transcripts within viral replication compartments. Journal of virology 87: 6693–6699.
36. YangPW, ChangSS, TsaiCH, ChaoYH, ChenMR (2008) Effect of phosphorylation on the transactivation activity of Epstein-Barr virus BMRF1, a major target of the viral BGLF4 kinase. J Gen Virol 89: 884–895.
37. AsaiR, KatoA, KawaguchiY (2009) Epstein-Barr virus protein kinase BGLF4 interacts with viral transactivator BZLF1 and regulates its transactivation activity. J Gen Virol 90: 1575–1581.
38. YueW, GershburgE, PaganoJS (2005) Hyperphosphorylation of EBNA2 by Epstein-Barr virus protein kinase suppresses transactivation of the LMP1 promoter. J Virol 79: 5880–5885.
39. KatoK, YokoyamaA, TohyaY, AkashiH, NishiyamaY, et al. (2003) Identification of protein kinases responsible for phosphorylation of Epstein-Barr virus nuclear antigen leader protein at serine-35, which regulates its coactivator function. J Gen Virol 84: 3381–3392.
40. WangJT, DoongSL, TengSC, LeeCP, TsaiCH, et al. (2009) Epstein-Barr virus BGLF4 kinase suppresses the interferon regulatory factor 3 signaling pathway. J Virol 83: 1856–1869.
41. WangJT, ChangLS, ChenCJ, DoongSL, ChangCW, et al. (2013) Glycogen synthase kinase 3 negatively regulates IFN regulatory factor 3 transactivation through phosphorylation at its linker region. Innate immunity 20 (1) 78–87.
42. ChangLS, WangJT, DoongSL, LeeCP, ChangCW, et al. (2012) Epstein-Barr Virus BGLF4 Kinase Down-regulates NF-kappaB Transactivation through Phosphorylation of Coactivator UXT. Journal of virology 86: 12176–12186.
43. MounceBC, MbokoWP, BigleyTM, TerhuneSS, TarakanovaVL (2013) A conserved gammaherpesvirus protein kinase targets histone deacetylases 1 and 2 to facilitate viral replication in primary macrophages. Journal of virology 87: 7314–7325.
44. LiR, ZhuJ, XieZ, LiaoG, LiuJ, et al. (2011) Conserved Herpesvirus Kinases Target the DNA Damage Response Pathway and TIP60 Histone Acetyltransferase to Promote Virus Replication. Cell host & microbe 10: 390–400.
45. LiR, WangL, LiaoG, GuzzoCM, MatunisMJ, et al. (2012) SUMO binding by the Epstein-Barr virus protein kinase BGLF4 is crucial for BGLF4 function. Journal of virology 86: 5412–5421.
46. HagemeierSR, BarlowEA, MengQ, KenneySC (2012) The cellular ataxia telangiectasia-mutated kinase promotes epstein-barr virus lytic reactivation in response to multiple different types of lytic reactivation-inducing stimuli. Journal of virology 86: 13360–13370.
47. FeederleR, Mehl-LautschamAM, BannertH, DelecluseHJ (2009) The Epstein-Barr virus protein kinase BGLF4 and the exonuclease BGLF5 have opposite effects on the regulation of viral protein production. J Virol 83: 10877–10891.
48. LeeCP, ChenMR (2010) Escape of herpesviruses from the nucleus. Reviews in medical virology 20: 214–230.
49. RoweM, GlaunsingerB, van LeeuwenD, ZuoJ, SweetmanD, et al. (2007) Host shutoff during productive Epstein-Barr virus infection is mediated by BGLF5 and may contribute to immune evasion. Proc Natl Acad Sci U S A 104: 3366–3371.
50. CountrymanJ, GradovilleL, Bhaduri-McIntoshS, YeJ, HestonL, et al. (2009) Stimulus duration and response time independently influence the kinetics of lytic cycle reactivation of Epstein-Barr virus. Journal of virology 83: 10694–10709.
51. YeJ, GradovilleL, DaigleD, MillerG (2007) De novo protein synthesis is required for lytic cycle reactivation of Epstein-Barr virus, but not Kaposi's sarcoma-associated herpesvirus, in response to histone deacetylase inhibitors and protein kinase C agonists. Journal of virology 81: 9279–9291.
52. GershburgE, PaganoJS (2002) Phosphorylation of the Epstein-Barr virus (EBV) DNA polymerase processivity factor EA-D by the EBV-encoded protein kinase and effects of the L-riboside benzimidazole 1263W94. J Virol 76: 998–1003.
53. CarreraAC, AlexandrovK, RobertsTM (1993) The conserved lysine of the catalytic domain of protein kinases is actively involved in the phosphotransfer reaction and not required for anchoring ATP. Proc Natl Acad Sci U S A 90: 442–446.
54. El-GuindyA, Ghiassi-NejadM, GoldenS, DelecluseHJ, MillerG (2013) Essential role of rta in lytic DNA replication of epstein-barr virus. J Virol 87: 208–223.
55. NeuhierlB, DelecluseHJ (2006) The Epstein-Barr virus BMRF1 gene is essential for lytic virus replication. Journal of virology 80: 5078–5081.
56. LengN, DawsonJA, ThomsonJA, RuottiV, RissmanAI, et al. (2013) EBSeq: an empirical Bayes hierarchical model for inference in RNA-seq experiments. Bioinformatics 29: 1035–1043.
57. LiB, DeweyCN (2011) RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC bioinformatics 12: 323.
58. YuanJ, Cahir-McFarlandE, ZhaoB, KieffE (2006) Virus and cell RNAs expressed during Epstein-Barr virus replication. Journal of virology 80: 2548–2565.
59. LoesingJB, Di FioreS, RitterK, FischerR, KleinesM (2009) Epstein-Barr virus BDLF2-BMRF2 complex affects cellular morphology. The Journal of general virology 90: 1440–1449.
60. JohannsenE, LuftigM, ChaseMR, WeickselS, Cahir-McFarlandE, et al. (2004) Proteins of purified Epstein-Barr virus. Proc Natl Acad Sci U S A 101: 16286–16291.
61. BeisserPS, VerzijlD, GruijthuijsenYK, BeukenE, SmitMJ, et al. (2005) The Epstein-Barr virus BILF1 gene encodes a G protein-coupled receptor that inhibits phosphorylation of RNA-dependent protein kinase. Journal of virology 79: 441–449.
62. O'GradyT, CaoS, StrongMJ, ConchaM, WangX, et al. (2014) Global Bidirectional Transcription of the Epstein-Barr Virus Genome during Reactivation. Journal of virology 88: 1604–1616.
63. ChenMR, HsuTY, ChenJY, YangCS (1990) Molecular characterization of a cDNA clone encoding the Epstein-Barr virus (EBV) DNase. J Virol Methods 29: 127–141.
64. HaqueM, WangV, DavisDA, ZhengZM, YarchoanR (2006) Genetic organization and hypoxic activation of the Kaposi's sarcoma-associated herpesvirus ORF34-37 gene cluster. J Virol 80: 7037–7051.
65. HaqueM, KousoulasKG (2013) The Kaposi's sarcoma-associated herpesvirus ORF34 protein binds to HIF-1alpha and causes its degradation via the proteasome pathway. Journal of virology 87: 2164–2173.
66. FrancisAL, GradovilleL, MillerG (1997) Alteration of a single serine in the basic domain of the Epstein-Barr virus ZEBRA protein separates its functions of transcriptional activation and disruption of latency. J Virol 71: 3054–3061.
67. FeederleR, KostM, BaumannM, JanzA, DrouetE, et al. (2000) The Epstein-Barr virus lytic program is controlled by the co-operative functions of two transactivators. Embo J 19: 3080–3089.
68. DelecluseHJ, HilsendegenT, PichD, ZeidlerR, HammerschmidtW (1998) Propagation and recovery of intact, infectious Epstein-Barr virus from prokaryotic to human cells. Proc Natl Acad Sci U S A 95: 8245–8250.
69. PearsonGR, VromanB, ChaseB, SculleyT, HummelM, et al. (1983) Identification of polypeptide components of the Epstein-Barr virus early antigen complex with monoclonal antibodies. J Virol 47: 193–201.
70. SongY, NagyM, NiW, TyagiNK, FentonWA, et al. (2013) Molecular chaperone Hsp110 rescues a vesicle transport defect produced by an ALS-associated mutant SOD1 protein in squid axoplasm. Proceedings of the National Academy of Sciences of the United States of America 110: 5428–5433.
71. TrapnellC, PachterL, SalzbergSL (2009) TopHat: discovering splice junctions with RNA-Seq. Bioinformatics 25: 1105–1111.
72. LangmeadB, SalzbergSL (2012) Fast gapped-read alignment with Bowtie 2. Nature methods 9: 357–359.
73. BaerR, BankierAT, BigginMD, DeiningerPL, FarrellPJ, et al. (1984) DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature 310: 207–211.